CoChat

A Peptide Derived from G0/G1 Switch Gene 2 Acts as Noncompetitive Inhibitor of Adipose Triglyceride Lipase

Open access
Cerk, Ines K., Salzburger, Barbara, Boeszoermenyi, Andras, Heier, Christoph, Pillip, Christoph, Romauch, Matthias, Schweiger, Martina, Cornaciu, Irina, Lass, Achim, Zimmermann, Robert, Zechner, Rudolf, Oberer, Monika · 2014 · Journal of Biological Chemistry
Cited by 45

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The protein G0/G1 switch gene 2 (G0S2) is a small basic protein that functions as an endogenous inhibitor of adipose triglyceride lipase (ATGL), a key enzyme in intracellular lipolysis. In this study, we identified a short sequence covering residues Lys-20 to Ala-52 in G0S2 that is still fully capable of inhibiting mouse and human ATGL. We found that a synthetic peptide corresponding to this region inhibits ATGL in a noncompetitive manner in the nanomolar range. This peptide is highly selective for ATGL and does not inhibit other lipases, including hormone-sensitive lipase, monoacylglycerol lipase, lipoprotein lipase, and patatin domain-containing phospholipases 6 and 7. Because increased lipolysis is linked to the development of metabolic disorders, the inhibition of ATGL by G0S2-derived peptides may represent a novel therapeutic tool to modulate lipolysis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m114.602599

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 52

  1. Li, 2010, Acyl-CoA synthesis, lipid metabolism and lipotoxicity, Biochim. Biophys. Acta, 1801, 246, 10.1016/j.bbalip.2009.09.024 · DOI · Paper page
  2. Unger, 2010, Lipid homeostasis, lipotoxicity and the metabolic syndrome, Biochim. Biophys. Acta, 1801, 209, 10.1016/j.bbalip.2009.10.006 · DOI · Paper page
  3. Mittendorfer, 2009, Relationship between body fat mass and free fatty acid kinetics in men and women, Obesity, 17, 1872, 10.1038/oby.2009.224 · DOI · Paper page
  4. Zimmermann, 2004, Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase, Science, 306, 1383, 10.1126/science.1100747 · DOI · Paper page
  5. Schweiger, 2009, Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5, Am. J. Physiol. Endocrinol. Metab, 297, E289, 10.1152/ajpendo.00099.2009 · DOI · Paper page
  6. Mayer, 2013, Development of small-molecule inhibitors targeting adipose triglyceride lipase, Nat. Chem. Biol, 9, 785, 10.1038/nchembio.1359 · DOI · Paper page
  7. Das, 2011, Adipose triglyceride lipase contributes to cancer-associated cachexia, Science, 333, 233, 10.1126/science.1198973 · DOI · Paper page
  8. Lass, 2011, Lipolysis–a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores, Prog. Lipid Res, 50, 14, 10.1016/j.plipres.2010.10.004 · DOI · Paper page
  9. Nagy, 2014, Adipose triglyceride lipase activity is inhibited by long-chain acyl-coenzyme A, Biochim. Biophys. Acta, 1841, 588, 10.1016/j.bbalip.2014.01.005 · DOI · Paper page
  10. Lass, 2006, Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome, Cell Metab, 3, 309, 10.1016/j.cmet.2006.03.005 · DOI · Paper page
  11. Cornaciu, 2011, The minimal domain of adipose triglyceride lipase (ATGL) ranges until leucine 254 and can be activated and inhibited by CGI-58 and G0S2, respectively, PLoS One, 6, e26349, 10.1371/journal.pone.0026349 · DOI · Paper page
  12. Heckmann, 2014, Defective adipose lipolysis and altered global energy metabolism in mice with adipose overexpression of the lipolytic inhibitor G0/G1 switch gene 2 (G0S2), J. Biol. Chem, 289, 1905, 10.1074/jbc.M113.522011 · DOI
  13. Lu, 2010, Differential control of ATGL-mediated lipid droplet degradation by CGI-58 and G0S2, Cell Cycle, 9, 2719, 10.4161/cc.9.14.12181 · DOI · Paper page
  14. Schweiger, 2012, G0/G1 switch gene-2 regulates human adipocyte lipolysis by affecting activity and localization of adipose triglyceride lipase, J. Lipid Res, 53, 2307, 10.1194/jlr.M027409 · DOI · Paper page
  15. Wang, 2013, The G0/G1 switch gene 2 is an important regulator of hepatic triglyceride metabolism, PLoS One, 8, e72315, 10.1371/journal.pone.0072315 · DOI
  16. Yang, 2010, The G0/G1 switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase, Cell Metab, 11, 194, 10.1016/j.cmet.2010.02.003 · DOI · Paper page
  17. Yang, 2011, Relative contribution of adipose triglyceride lipase and hormone-sensitive lipase to tumor necrosis factor-α (TNF-α)-induced lipolysis in adipocytes, J. Biol. Chem, 286, 40477, 10.1074/jbc.M111.257923 · DOI · Paper page
  18. Bächner, 1998, Bmp-2 downstream targets in mesenchymal development identified by subtractive cloning from recombinant mesenchymal progenitors (C3H10T1/2), Dev. Dyn, 213, 398, 10.1002/(SICI)1097-0177(199812)213:4<398::AID-AJA5>3.0.CO;2-T · DOI
  19. Zandbergen, 2005, The G0/G1 switch gene 2 is a novel PPAR target gene, Biochem. J, 392, 313, 10.1042/BJ20050636 · DOI · Paper page
  20. Choi, 2014, G0/G1 switch gene 2 has a critical role in adipocyte differentiation, Cell Death Differ, 21, 1071, 10.1038/cdd.2014.26 · DOI
  21. Ma, 2014, Mice lacking G0S2 are lean and cold-tolerant, Cancer Biol. Ther, 15, 643, 10.4161/cbt.28251 · DOI
  22. Zhang, 2014, Targeted disruption of G0/G1 switch gene 2 enhances adipose lipolysis, alters hepatic energy balance, and alleviates high-fat diet-induced liver steatosis, Diabetes, 63, 934, 10.2337/db13-1422 · DOI
  23. Nielsen, 2014, Adipose triglyceride lipase and G0/G1 switch gene 2: approaching proof of concept, Diabetes, 63, 847, 10.2337/db13-1838 · DOI
  24. Ma, 2006, ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver, J. Biol. Chem, 281, 28721, 10.1074/jbc.M601576200 · DOI · Paper page
  25. Nielsen, 2012, Reduced mRNA and protein expression of perilipin A and G0/G1 switch gene 2 (G0S2) in human adipose tissue in poorly controlled type 2 diabetes, J. Clin. Endocrinol. Metab, 97, E1348, 10.1210/jc.2012-1159 · DOI
  26. Yamada, 2012, The cytosolic protein G0S2 maintains quiescence in hematopoietic stem cells, PLoS One, 7, e38280, 10.1371/journal.pone.0038280 · DOI
  27. Yamada, 2014, G0S2 inhibits the proliferation of K562 cells by interacting with nucleolin in the cytosol, Leuk. Res, 38, 210, 10.1016/j.leukres.2013.10.006 · DOI
  28. Welch, 2009, Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2, Cancer Res, 69, 6782, 10.1158/0008-5472.CAN-09-0128 · DOI · Paper page
  29. Cristillo, 1997, Cyclosporin A inhibits early mRNA expression of G0/G1 switch gene 2 (G0S2) in cultured human blood mononuclear cells, DNA Cell Biol, 16, 1449, 10.1089/dna.1997.16.1449 · DOI
  30. Koczan, 2005, Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules, Eur. J. Dermatol, 15, 251
  31. Russell, 1991, A human putative lymphocyte G0/G1 switch gene containing a CpG-rich island encodes a small basic protein with the potential to be phosphorylated, DNA Cell Biol, 10, 581, 10.1089/dna.1991.10.581 · DOI · Paper page
  32. Kioka, 2014, Evaluation of intramitochondrial ATP levels identifies G0/G1 switch gene 2 as a positive regulator of oxidative phosphorylation, Proc. Natl. Acad. Sci. U.S.A, 111, 273, 10.1073/pnas.1318547111 · DOI
  33. Kusakabe, 2010, Identification of G0S2 as a gene frequently methylated in squamous lung cancer by combination of in silico and experimental approaches, Int. J. Cancer, 126, 1895, 10.1002/ijc.24947 · DOI
  34. Kusakabe, 2009, Impact of DNA demethylation of the G0S2 gene on the transcription of G0S2 in squamous lung cancer cell lines with or without nuclear receptor agonists, Biochem. Biophys. Res. Commun, 390, 1283, 10.1016/j.bbrc.2009.10.137 · doi:10.1016/j.bbrc.2009.10.137
  35. Tokumaru, 2004, Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing, Cancer Res, 64, 5982, 10.1158/0008-5472.CAN-04-0993 · DOI
  36. Gruber, 2010, The N-terminal region of comparative gene identification-58 (CGI-58) is important for lipid droplet binding and activation of adipose triglyceride lipase, J. Biol. Chem, 285, 12289, 10.1074/jbc.M109.064469 · DOI
  37. Heier, 2010, Identification of Yju3p as functional orthologue of mammalian monoglyceride lipase in the yeast Saccharomyces cerevisiae, Biochim. Biophys. Acta, 1801, 1063, 10.1016/j.bbalip.2010.06.001 · DOI · Paper page
  38. Kienesberger, 2008, Identification of an insulin-regulated lysophospholipase with homology to neuropathy target esterase, J. Biol. Chem, 283, 5908, 10.1074/jbc.M709598200 · DOI
  39. Schweiger, 2014, Measurement of lipolysis, Methods Enzymol, 538, 171, 10.1016/B978-0-12-800280-3.00010-4 · DOI · Paper page
  40. Taschler, 2011, Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance, J. Biol. Chem, 286, 17467, 10.1074/jbc.M110.215434 · DOI · Paper page
  41. Dixon, 1953, The determination of enzyme inhibitor constants, Biochem. J, 55, 170, 10.1042/bj0550170 · DOI · Paper page
  42. Schweiger, 2006, Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism, J. Biol. Chem, 281, 40236, 10.1074/jbc.M608048200 · DOI · Paper page
  43. Ebdrup, 2004, Synthesis and structure-activity relationship for a novel class of potent and selective carbamoyl-triazole based inhibitors of hormone sensitive lipase, J. Med. Chem, 47, 400, 10.1021/jm031004s · DOI
  44. Kienesberger, 2009, Mammalian patatin domain containing proteins: a family with diverse lipolytic activities involved in multiple biological functions, J. Lipid Res, 50, S63, 10.1194/jlr.R800082-JLR200 · DOI · Paper page
  45. Hoy, 2011, Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation, Endocrinology, 152, 48, 10.1210/en.2010-0661 · DOI · Paper page
  46. Severson, 1984, Inhibition of the hormone-sensitive lipase in adipose tissue by long-chain fatty acyl coenzyme A, Lipids, 19, 134, 10.1007/BF02534504 · doi:10.1007/bf02534504
  47. Kumari, 2012, Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase, Cell Metab, 15, 691, 10.1016/j.cmet.2012.04.008 · DOI · Paper page
  48. Hirano, 2009, A novel clinical entity: triglyceride deposit cardiomyovasculopathy, J. Atheroscler. Thromb, 16, 702, 10.5551/jat.1669 · DOI
  49. Gray, 2014, Combinatorial peptide libraries: mining for cell-binding peptides, Chem. Rev, 114, 1020, 10.1021/cr400166n · DOI · Paper page
  50. Hossen, 2010, Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue, J. Control Release, 147, 261, 10.1016/j.jconrel.2010.07.100 · DOI
  51. Kolonin, 2004, Reversal of obesity by targeted ablation of adipose tissue, Nat. Med, 10, 625, 10.1038/nm1048 · DOI · Paper page
  52. Schweiger, 2008, The C-terminal region of human adipose triglyceride lipase affects enzyme activity and lipid droplet binding, J. Biol. Chem, 283, 17211, 10.1074/jbc.M710566200 · DOI · Paper page

Cited by

See all 45

Metadata

Authors
Cerk, I. K., Salzburger, B., Boeszoermenyi, A., Heier, C., Pillip, C., Romauch, M., Schweiger, M., Cornaciu, I., Lass, A., Zimmermann, R., Zechner, R., & Oberer, M.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2014-11
Volume
289
Issue
47
Pages
32559-32570
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1994146146
Cited by
45
References
7
FWCI
1.57
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.